Cargando…

An anti vimentin antibody promotes tube formation

In recent years, there has been an increasing appreciation of the importance of secreted and extracellular proteins that traditionally have been considered as intracellular components. Vimentin is a highly abundant intermediate filament protein, and its intracellular functions have been investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Mathias Lindh, Møller, Carina Kjeldahl, Rasmussen, Lasse, Boisen, Louise, Pedersen, Henrik, Kristensen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472577/
https://www.ncbi.nlm.nih.gov/pubmed/28620205
http://dx.doi.org/10.1038/s41598-017-03799-2
_version_ 1783244134310477824
author Jørgensen, Mathias Lindh
Møller, Carina Kjeldahl
Rasmussen, Lasse
Boisen, Louise
Pedersen, Henrik
Kristensen, Peter
author_facet Jørgensen, Mathias Lindh
Møller, Carina Kjeldahl
Rasmussen, Lasse
Boisen, Louise
Pedersen, Henrik
Kristensen, Peter
author_sort Jørgensen, Mathias Lindh
collection PubMed
description In recent years, there has been an increasing appreciation of the importance of secreted and extracellular proteins that traditionally have been considered as intracellular components. Vimentin is a highly abundant intermediate filament protein, and its intracellular functions have been investigated in a large number of studies. Recently, however, vimentin has been shown to take part in significant processes outside the cell. Our understanding of the functions of extracellular vimentin is, however, limited. In this study we demonstrate that a vimentin specific antibody, obtained by phage antibody technology, promotes tube formation of endothelial cells in a 2D matrigel assay. By binding vimentin, the antibody increases the tube formation by 21% after 5 hours of incubation. Addition of the antibody directly to cultured endothelial cells does not influence endothelial cell migration or proliferation. The enhanced tube formation can be seen for up to 10 hours where after the effect decreases. It is shown that the antibody-binding site is located on the coil 2 domain of vimentin. To our knowledge this is the first study that demonstrates an enhanced tube formation by binding vimentin in a 2D matrigel assay under normoxic conditions.
format Online
Article
Text
id pubmed-5472577
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54725772017-06-21 An anti vimentin antibody promotes tube formation Jørgensen, Mathias Lindh Møller, Carina Kjeldahl Rasmussen, Lasse Boisen, Louise Pedersen, Henrik Kristensen, Peter Sci Rep Article In recent years, there has been an increasing appreciation of the importance of secreted and extracellular proteins that traditionally have been considered as intracellular components. Vimentin is a highly abundant intermediate filament protein, and its intracellular functions have been investigated in a large number of studies. Recently, however, vimentin has been shown to take part in significant processes outside the cell. Our understanding of the functions of extracellular vimentin is, however, limited. In this study we demonstrate that a vimentin specific antibody, obtained by phage antibody technology, promotes tube formation of endothelial cells in a 2D matrigel assay. By binding vimentin, the antibody increases the tube formation by 21% after 5 hours of incubation. Addition of the antibody directly to cultured endothelial cells does not influence endothelial cell migration or proliferation. The enhanced tube formation can be seen for up to 10 hours where after the effect decreases. It is shown that the antibody-binding site is located on the coil 2 domain of vimentin. To our knowledge this is the first study that demonstrates an enhanced tube formation by binding vimentin in a 2D matrigel assay under normoxic conditions. Nature Publishing Group UK 2017-06-15 /pmc/articles/PMC5472577/ /pubmed/28620205 http://dx.doi.org/10.1038/s41598-017-03799-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Jørgensen, Mathias Lindh
Møller, Carina Kjeldahl
Rasmussen, Lasse
Boisen, Louise
Pedersen, Henrik
Kristensen, Peter
An anti vimentin antibody promotes tube formation
title An anti vimentin antibody promotes tube formation
title_full An anti vimentin antibody promotes tube formation
title_fullStr An anti vimentin antibody promotes tube formation
title_full_unstemmed An anti vimentin antibody promotes tube formation
title_short An anti vimentin antibody promotes tube formation
title_sort anti vimentin antibody promotes tube formation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472577/
https://www.ncbi.nlm.nih.gov/pubmed/28620205
http://dx.doi.org/10.1038/s41598-017-03799-2
work_keys_str_mv AT jørgensenmathiaslindh anantivimentinantibodypromotestubeformation
AT møllercarinakjeldahl anantivimentinantibodypromotestubeformation
AT rasmussenlasse anantivimentinantibodypromotestubeformation
AT boisenlouise anantivimentinantibodypromotestubeformation
AT pedersenhenrik anantivimentinantibodypromotestubeformation
AT kristensenpeter anantivimentinantibodypromotestubeformation
AT jørgensenmathiaslindh antivimentinantibodypromotestubeformation
AT møllercarinakjeldahl antivimentinantibodypromotestubeformation
AT rasmussenlasse antivimentinantibodypromotestubeformation
AT boisenlouise antivimentinantibodypromotestubeformation
AT pedersenhenrik antivimentinantibodypromotestubeformation
AT kristensenpeter antivimentinantibodypromotestubeformation